RBC Capital Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $664
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara maintains an Outperform rating on Thermo Fisher Scientific (NYSE:TMO) and raises the price target from $660 to $664.
July 25, 2024 | 5:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reaffirmed its Outperform rating on Thermo Fisher Scientific and slightly increased the price target from $660 to $664.
The reaffirmation of an Outperform rating and a slight increase in the price target by RBC Capital is a positive signal for investors, indicating confidence in Thermo Fisher Scientific's performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100